BiOptic Inc. is stepping into the Fast Growing Period of Business!
2015-11-01
In the year 2011, BiOptic Inc. strategically entered the biomolecules analysis (nucleic acid testing) market by launching the newly designed fully automated, single-channel Capillary Gel Electrophoresis instrument; the patented Qsep100TM product.
HAYWARD, Calif.--(BUSINESS WIRE)--ProZyme, Inc., manufacturer of bioreagents for glycobiology, and BiOptic Inc. of Taiwan, manufacturer of instruments for DNA analysis by capillary gel electrophoresis (CGE), today announce an agreement to collaborate on the development and commercialization of an integrated system (Gly-Q™) for high-throughput, user-friendly glycoanalysis. The Gly-Q collaboration will extend ProZyme’s portfolio of glycobiology products, and will leverage BiOptic’s line of rugged and accurate CGE instruments.
